These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3410260)

  • 1. [Enhancement of the efficacy of cytostatic therapy of experimental leukemia by using a water-soluble complex of splenic blood-regulating factors].
    Svirnovskiĭ AI; Shimanskaia TV; Bakun AV
    Gematol Transfuziol; 1988 May; 33(5):16-9. PubMed ID: 3410260
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isolation of an extract from regenerating splenic tissue inhibiting DNA synthesis predominantly in leukemic cells].
    Svirnovskiĭ AI; Shimanskaia TV; Ageĭchik VM; Bakun AV; Levin VI
    Gematol Transfuziol; 1983 Apr; 28(4):24-8. PubMed ID: 6852509
    [No Abstract]   [Full Text] [Related]  

  • 3. [The potential for enhancing the therapeutic efficacy of antitumor preparations].
    Konovalova NP; Volkova LM; Klochko AV
    Izv Akad Nauk SSSR Biol; 1989; (3):466-8. PubMed ID: 2760333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
    Bortin MM; Rimm AA; Rodey GE; Giller R; Saltzstein EC
    Cancer Res; 1974 Aug; 34(8):1851-6. PubMed ID: 4152270
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reaction of hematopoietic tissue to the administration of an antileukemic substance isolated from splenic tissue].
    Svirnovskiĭ AI; Shimanskaia TV; Bakun AV; Levin VI
    Gematol Transfuziol; 1985 Oct; 30(10):34-7. PubMed ID: 4065523
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction of the antileukemic activity in nonimmune allogeneic splenocytes using spleen hemoregulators].
    Svirnovskiĭ AI; Shimanskaia TV; Bakun AV; Ageĭchik VM
    Eksp Onkol; 1988; 10(5):57-61. PubMed ID: 3208692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tissue specific mitotic inhibitors on survival time of spontaneous and virus-induced murine leukaemia and influence on myocardial degeneration.
    Ebbesen P; Olsson L
    Scand J Haematol; 1978 Aug; 21(2):131-8. PubMed ID: 694424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The radioprotective action of an extract of regenerating spleen].
    Svirnovskiĭ AI; Shimanskaia TV; Bakun AV
    Radiobiologiia; 1993; 33(1):141-7. PubMed ID: 8469736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of androgens on the development of leukemia in AKR-strain mice].
    Lisukov IA; Tsyrlova IG; Kozlov VA
    Eksp Onkol; 1986; 8(1):71-3, 79. PubMed ID: 3753930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunochemotherapy of a transplantable AKR leukemia (K36).
    Putman DL; Kind PD; Goldin A; Kende M
    Int J Cancer; 1978 Feb; 21(2):230-3. PubMed ID: 24004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased life-span in AKR leukemia mice treated with prophylactic chemotherapy.
    Straus MJ; Choi SC; Goldin A
    Cancer Res; 1973 Jul; 33(7):1724-8. PubMed ID: 4721231
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possible mechanism of the alteration in the therapeutic action of cyclophosphane in mice with hemocytoblastosis La against a background of artificial hyperglycemia].
    Kabieva AO; Donenko FV
    Eksp Onkol; 1988; 10(4):66-8, 71. PubMed ID: 3181078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immunotherapy and combined chemo-immunotherapy in transplantable leukaemia of AKR mice (TAL); occurrence of natural killers.
    Schneiberg K; Rytwiński K; Tabeńska J
    Haematologia (Budap); 1981; 14(2):137-46. PubMed ID: 7274781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic activity of pretazettine, a narcissus alkaloid, on spontaneous AKR leukemia.
    Furusawa E; Lockwood RH; Furusawa S; Lum MK; Lee JY
    Chemotherapy; 1979; 25(5):308-15. PubMed ID: 225136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cure of acute leukaemia L 5222 in rats by a single course of treatment with vincristin and cyclophosphamide, or 1,3-bis-(2-chloroethyl)-1-nitroso-urea (BCNU) and cyclophosphamide (author's transl)].
    Zeller WJ; Schmähl D; Ivankovic S
    Dtsch Med Wochenschr; 1974 Jun; 99(25):1367-8. PubMed ID: 4836074
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of DNA synthesis in vitro in normal and leukemic spleen cells after administration of a lyophilized aqueous extract of normal spleen tissue].
    Svirnovskiĭ AI; Shimanskaia TV; Ageĭchik VM; Levin VI
    Biull Eksp Biol Med; 1981 Jun; 91(6):715-7. PubMed ID: 7272490
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of the kinetic parameters of tumor growth and an evaluation of the antitumor activity of chemotherapeutic preparations based on life expectancy].
    Konradov AA; Dronova LM; Erokhin VN; Belich EI; Korman DB
    Izv Akad Nauk SSSR Biol; 1982; (3):419-27. PubMed ID: 7096779
    [No Abstract]   [Full Text] [Related]  

  • 20. Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems.
    Fefer A; Einstein AB; Cheever MA
    Ann N Y Acad Sci; 1976; 277(00):492-504. PubMed ID: 793486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.